Thierry Landre
10PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué
|Feb 02, 2024
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC).Thierry Landre, Christos Chouaïd, Nassyma Sadaoui
|Dec 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis.Gaëtan Des Guetz, Thierry Landre, Marc A Bollet
|Aug 11, 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.Thierry Landre, Gregoire Justeau, Jean-Baptiste Assié
|Apr 03, 2021
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis.Sébastien Gendarme, Helene Goussault, Jean-Baptiste Assié
Pageof 2